#Indian#Pharma companies are facing a lot of backlash when it comes to export of pharma products outside India or asia. Now that Wockdart has cleared the inspection of German drug regulator it will be cover the loss suffered during the warning submitted by (USFDA). In general Indian Pharma companies have to comply with USFDA practices if they want to attain a niche in global markets this includes big giants like Sun Pharma. Continuing, the Indian stock market has taken a hit due to the government's demonetization or banning of Rs 500 and Rs 1000 notes. It will take some time for the market to recover. However, Pharma companies won't be affected as others due to majority of its sale come from export which are paid in dollars. Well the next quarter report would tell how shift in monetary policy has affected the Pharma sector.
Sensex Ends Lower; IT Stocks Slump 2.4% on Worries Over H-1B Visas
#Indian #Pharma companies are facing a lot of backlash when it comes to export of pharma products outside India or asia. Now that Wockdart has cleared the inspection of German drug regulator it will be cover the loss suffered during the warning submitted by (USFDA). In general Indian Pharma companies have to comply with USFDA practices if they want to attain a niche in global markets this includes big giants like Sun Pharma. Continuing, the Indian stock market has taken a hit due to the government's demonetization or banning of Rs 500 and Rs 1000 notes. It will take some time for the market to recover. However, Pharma companies won't be affected as others due to majority of its sale come from export which are paid in dollars. Well the next quarter report would tell how shift in monetary policy has affected the Pharma sector.